The document presents consolidated statements of profit or loss for years 2018 to 2022. It shows that sales increased steadily each year, rising from Rs. 33 billion in 2018 to Rs. 62 billion in 2022. However, cost of sales increased at a higher rate than sales each year. As a result, gross profit declined from 2018 to 2020 before increasing in 2021 and 2022. Profits fluctuated over the years, with the highest profit for the year of Rs. 4.1 billion achieved in 2021.
The document presents consolidated statements of profit or loss for years 2018 to 2022. It shows that sales increased steadily each year, rising from Rs. 33 billion in 2018 to Rs. 62 billion in 2022. However, cost of sales increased at a higher rate than sales each year. As a result, gross profit declined from 2018 to 2020 before increasing in 2021 and 2022. Profits fluctuated over the years, with the highest profit for the year of Rs. 4.1 billion achieved in 2021.
The document presents consolidated statements of profit or loss for years 2018 to 2022. It shows that sales increased steadily each year, rising from Rs. 33 billion in 2018 to Rs. 62 billion in 2022. However, cost of sales increased at a higher rate than sales each year. As a result, gross profit declined from 2018 to 2020 before increasing in 2021 and 2022. Profits fluctuated over the years, with the highest profit for the year of Rs. 4.1 billion achieved in 2021.
The document presents consolidated statements of profit or loss for years 2018 to 2022. It shows that sales increased steadily each year, rising from Rs. 33 billion in 2018 to Rs. 62 billion in 2022. However, cost of sales increased at a higher rate than sales each year. As a result, gross profit declined from 2018 to 2020 before increasing in 2021 and 2022. Profits fluctuated over the years, with the highest profit for the year of Rs. 4.1 billion achieved in 2021.
Cost of sales 100% 154% Gross profit 100% 64% Administrative expenses 100% 101% Selling and distribution expenses 100% 145% Net impairment losses on financial assets Changes in fair value of biological assets 100% 138% Other expenses 100% 21% Other income 100% 82% Finance cost 100% 628% Profit before taxation 100% 31% Taxation 100% -26% Profit for the year 100% 21% Profit is attributable to: Equity holders of the parent company 100% 21% Non-controlling interests 100% 61% 100% 21% Earnings per share - basic and diluted in Rupees 20.25 4.16 INDEX 2020 2021 2022